...
首页> 外文期刊>Fluids and Barriers of the CNS >Detection of viral antigen, IgM and IgG antibodies in cerebrospinal fluid of Chikungunya patients with neurological complications
【24h】

Detection of viral antigen, IgM and IgG antibodies in cerebrospinal fluid of Chikungunya patients with neurological complications

机译:基孔肯雅热合并神经系统并发症患者脑脊液中病毒抗原,IgM和IgG抗体的检测

获取原文
           

摘要

Background During Chikungunya virus (CHIKV) epidemic in Nagpur, India, we identified some suspected Chikungunya patients with neurological complications. Early and cost-effective diagnosis of these patients remains problematic despite many new advanced diagnostic methods. A reliable diagnostic test, which could be performed in any standard pathology laboratory, would help to obtain definitive early diagnosis of CHIKV patients with neurological complications. In our laboratory, in-house ELISA protocol for viral antigen, immunoglobulin M (IgM) and IgG detection has been developed and assessed for the diagnosis of CHIKV patients with neurological complications. Method Cerebrospinal fluid samples of forty-six patients who developed neurological symptoms within two months of CHIKV infections along with control subjects were included in the study and were analyzed for the presence of antigens and of IgM and IgG using an ELISA protocol. Results The ELISA method for antigen detection yielded 80% sensitivity and 87% specificity for the diagnosis of CHIKV patients with neurological complications. The sensitivity for detection of IgM 48% or IgG 63% was significantly lower than the antigen assay (80%). Conclusion The detection of viral antigen in CSF of CHIKV patients with neurological complications by ELISA method gave a more reliable diagnosis than antibodies detection that can be used to develop an immunodiagnostic assay with increased sensitivity and specificity.
机译:背景在印度那格浦尔的基孔肯雅病毒(CHIKV)流行期间,我们发现了一些怀疑的基孔肯雅病患者,患有神经系统并发症。尽管有许多新的先进诊断方法,但对这些患者的早期且经济有效的诊断仍然存在问题。可以在任何标准病理实验室中执行的可靠诊断测试,将有助于获得具有神经系统并发症的CHIKV患者的明确早期诊断。在我们的实验室中,已经开发出用于病毒抗原,免疫球蛋白M(IgM)和IgG检测的内部ELISA方案,并评估了其对患有神经系统并发症的CHIKV患者的诊断。方法将46例在CHIKV感染后两个月内出现神经系统症状的患者的脑脊液样本与对照组一起纳入研究,并使用ELISA方案分析抗原,IgM和IgG的存在。结果用于抗原检测的ELISA方法对CHIKV神经系统并发症的诊断具有80%的敏感性和87%的特异性。 IgM 48%或IgG 63%的检测灵敏度显着低于抗原测定(80%)。结论ELISA法检测CHIKV神经系统并发症患者脑脊液中的病毒抗原比抗体检测更可靠,可用于开发具有更高灵敏度和特异性的免疫诊断方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号